HM Payson & Co. Has $272,000 Stake in Monsanto (MON)

HM Payson & Co. decreased its stake in Monsanto (NYSE:MON) by 16.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,330 shares of the basic materials company’s stock after selling 464 shares during the period. HM Payson & Co.’s holdings in Monsanto were worth $272,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in MON. Amalgamated Bank grew its holdings in Monsanto by 2.0% during the third quarter. Amalgamated Bank now owns 52,909 shares of the basic materials company’s stock worth $6,340,000 after purchasing an additional 1,022 shares during the period. Janus Henderson Group PLC grew its holdings in Monsanto by 57.1% during the third quarter. Janus Henderson Group PLC now owns 2,342,693 shares of the basic materials company’s stock worth $280,696,000 after purchasing an additional 851,369 shares during the period. South Dakota Investment Council grew its holdings in Monsanto by 445.3% during the third quarter. South Dakota Investment Council now owns 172,870 shares of the basic materials company’s stock worth $20,713,000 after purchasing an additional 141,170 shares during the period. Steward Partners Investment Advisory LLC bought a new position in Monsanto during the third quarter worth about $356,000. Finally, Signature Estate & Investment Advisors LLC grew its holdings in Monsanto by 3.1% during the fourth quarter. Signature Estate & Investment Advisors LLC now owns 142,575 shares of the basic materials company’s stock worth $16,650,000 after purchasing an additional 4,333 shares during the period. Institutional investors own 76.21% of the company’s stock.

How to Become a New Pot Stock Millionaire

Shares of MON stock opened at $117.15 on Friday. The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 1.05. The stock has a market cap of $51,807.32, a P/E ratio of 20.51, a price-to-earnings-growth ratio of 1.69 and a beta of 0.95. Monsanto has a 1 year low of $113.09 and a 1 year high of $124.20.

Monsanto (NYSE:MON) last issued its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.01). The company had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.77 billion. Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The company’s revenue was up .3% on a year-over-year basis. During the same quarter last year, the business earned $0.21 earnings per share. sell-side analysts anticipate that Monsanto will post 5.73 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, April 6th will be given a dividend of $0.54 per share. The ex-dividend date is Thursday, April 5th. This represents a $2.16 annualized dividend and a yield of 1.84%. Monsanto’s dividend payout ratio (DPR) is presently 39.85%.

A number of equities analysts recently commented on MON shares. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a report on Monday, December 11th. Deutsche Bank reiterated a “buy” rating on shares of Monsanto in a report on Tuesday, January 16th. Finally, Wells Fargo reiterated a “market perform” rating and set a $128.00 price target (up previously from $118.00) on shares of Monsanto in a report on Wednesday, January 17th. Eleven analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $127.30.

In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the firm’s stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total transaction of $966,735.00. Following the completion of the sale, the executive vice president now directly owns 56,743 shares in the company, valued at $6,772,277.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.79% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was published by Ticker Report and is the property of of Ticker Report. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be accessed at https://www.tickerreport.com/banking-finance/3295682/hm-payson-co-has-272000-stake-in-monsanto-mon.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Internxt  Price Up 48.1% This Week
Internxt Price Up 48.1% This Week
MyWish  Trading Up 10.4% Over Last 7 Days
MyWish Trading Up 10.4% Over Last 7 Days
Analysts Anticipate Yamana Gold Inc.  to Post $0.01 Earnings Per Share
Analysts Anticipate Yamana Gold Inc. to Post $0.01 Earnings Per Share
Analysts Expect Prospect Capital Co.  Will Post Earnings of $0.18 Per Share
Analysts Expect Prospect Capital Co. Will Post Earnings of $0.18 Per Share
GeoCoin  Market Capitalization Hits $9.85 Million
GeoCoin Market Capitalization Hits $9.85 Million
Comparing Enzo Biochem  & Its Rivals
Comparing Enzo Biochem & Its Rivals


© 2006-2018 Ticker Report. Google+.